Optimizing Duration and Dosing Frequency of Vonoprazan-Amoxicillin Dual Therapy for Helicobacter pylori: A Multicenter Randomized Trial

Helicobacter Pylori

Vonoprazan Improves Efficacy of Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Multicenter Randomized Controlled Trial

Helicobacter

Yan TL, Wang JH, Zhu RK, Zhai HL, Wang ZZ, Mao XL, Shen X, Xu P, Ma D, He XJ, Wang JW, Gao JG, Jiang LL, Sun K, Chen Y, Sang JZ, Liu XQ, Chen JE, Li L

doi: 10.1111/hel.70056

Helicobacter Pylori

Efficacy and Safety of Keverprazan-Amoxicillin Dual Regimen in Initial Eradication of Helicobacter pylori Infection: A Multicenter, Randomized Controlled Trial

Helicobacter

Wei S, Huang Z, Xiong H, Wu J, Mei D, Zhao J, Liu W, Liu Q, Lin Y, Liu F, Peng X, Chen H

doi: 10.1111/hel.70100

Helicobacter Pylori

Vonoprazan-tetracycline dual regimen as rescue therapy for Helicobacter pylori infection: randomized controlled trial

Gastroenterology

Gao W, Li J, Yang G, Du S, Ling T, Zhang X, Ye H, Xiong Y, Tian Y, Liu J, Liu B, Wang C, Cheng H

doi: 10.1053/j.gastro.2026.01.008

Helicobacter Pylori

Tegoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Phase III Multicenter Randomized Clinical Trial

Helicobacter

Park JY, Hong SJ, Choi IJ, Baik GH, Kim SM, Park JJ, Jeon SW, Kim KO, Lee SK, Jung HY, Oh JH, Park CH, Kim SW, Shim KN, Jee SR, Moon HS, Moon JS, Choi CW, Lee WS, Kim JG

doi: 10.1111/hel.70106

Helicobacter Pylori

Efficacy and Safety of Levofloxacin- Versus Moxifloxacin-Based Nitazoxanide Quadruple Therapy as Second-Line Treatment for Helicobacter pylori in Egypt: A Randomized Multicenter Trial

Helicobacter

El-Azab G, Abdel Salam S, Moustafa E, Abuoelhassan A, Shamseya A, Ellakany A, Abdelaal U, Assem M, Khalil F, Mahmoud A, Elsabaawy M, Hussein B, Ezz-Eldin M, Hassany S, Zaghloul N, Magdy M

doi: 10.1111/hel.70104

Helicobacter Pylori

An Open-Label Randomized Controlled Trial Comparing the Efficacy and Safety of a 7-Day Triple Therapy With Bismuth Versus 14-Day Standard Triple Therapy for Helicobacter pylori Eradication in Children and Adolescents

Helicobacter

Šterbenc A, Vratanar B, Mojškerc EM, Homan M

doi: 10.1111/hel.70103

Helicobacter Pylori

Comparison of Therapeutic Outcomes Between Concomitant Therapy and Tailored Therapy for Helicobacter pylori: A Multicenter, Prospective, and Randomized Study

Helicobacter

Cho YS, Kim SM, Kang SH, Moon HS, Sung JK, Bang KB, Ryou SH, Kim KB, Sul HJ, Lee SW

doi: 10.1111/hel.70040

Further Publications

Efficacy of a 7-day vonoprazan, sitafloxacin, and amoxicillin triple therapy as a fourth-line salvage regimen for refractory Helicobacter pylori infection

BMC Gastroenterol

Geeratragool T, Tansirichaiya S, Kamolvit W, Atthakitmongkol T, Leartsiwawinyu W, Thaipisuttikul I, Chuenprapai P, Leelakusolvong S, Limwong C, Maneerattanaporn M

doi: 10.1186/s12876-025-04226-x

Inflammatory Bowel Disease

Group-Delivered Mindfulness-Based Cognitive Therapy to Reduce Psychological Distress and Improve Sleep in Patients With Inflammatory Bowel Diseases: A Multicenter Randomized Controlled Trial (MindIBD)

Inflamm Bowel Dis

Ter Avest MM, Huijbers MJ, Horjus CS, Römkens TEH, Witteman EM, van Dop WA, Dresler M, Donders ART, Dijkstra G, Nissen LHC, Speckens AEM

doi: 10.1093/ibd/izaf116

Related content

Vonoprazan Improves Efficacy of Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Multicenter Randomized Controlled Trial

Efficacy and Safety of Keverprazan-Amoxicillin Dual Regimen in Initial Eradication of Helicobacter pylori Infection: A Multicenter, Randomized Controlled Trial

Vonoprazan-tetracycline dual regimen as rescue therapy for Helicobacter pylori infection: randomized controlled trial

Tegoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Phase III Multicenter Randomized Clinical Trial

Efficacy and Safety of Levofloxacin- Versus Moxifloxacin-Based Nitazoxanide Quadruple Therapy as Second-Line Treatment for Helicobacter pylori in Egypt: A Randomized Multicenter Trial

An Open-Label Randomized Controlled Trial Comparing the Efficacy and Safety of a 7-Day Triple Therapy With Bismuth Versus 14-Day Standard Triple Therapy for Helicobacter pylori Eradication in Children and Adolescents

Comparison of Therapeutic Outcomes Between Concomitant Therapy and Tailored Therapy for Helicobacter pylori: A Multicenter, Prospective, and Randomized Study

Efficacy of a 7-day vonoprazan, sitafloxacin, and amoxicillin triple therapy as a fourth-line salvage regimen for refractory Helicobacter pylori infection

Group-Delivered Mindfulness-Based Cognitive Therapy to Reduce Psychological Distress and Improve Sleep in Patients With Inflammatory Bowel Diseases: A Multicenter Randomized Controlled Trial (MindIBD)